Resource
This asthma action plan is specifically for patients using the combination medication Symbicort (budesonide and formoterol) as an anti-inflammatory reliever with or without maintenance.
Note: Symbicort is not recommended for use in Australia in children under 12 years.
The Symbicort asthma action plans were independently developed by clinicians. Hard copies can be ordered from AstraZeneca via local representatives or by calling 1800 805 342.
These are symptom based asthma action plans. Copies of the peak flow based action plan are available from AstraZeneca.
Last reviewed 1 Mar 2021